CL
58
2
URBN
56
14
DG
6
2
COF
60
2
HST
49
-9
HPE
63
2
ES
34
3
KMI
67
-2
PM
62
-2
PYPL
54
2
PFE
23
7
GPC
40
3
WFC
79
4
HP
48
3
ROST
63
12
ZION
65
2
A
43
2
EQIX
64
2
CSCO
67
4
KHC
24
13
CL
58
2
URBN
56
14
DG
6
2
COF
60
2
HST
49
-9
HPE
63
2
ES
34
3
KMI
67
-2
PM
62
-2
PYPL
54
2
PFE
23
7
GPC
40
3
WFC
79
4
HP
48
3
ROST
63
12
ZION
65
2
A
43
2
EQIX
64
2
CSCO
67
4
KHC
24
13
Financhill
Back

Cartesian Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
40

RNAC
Cartesian Therapeutics

Last Price:
18.99
Seasonality Move:
13.13%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
1.46%
Sell
40
Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics a Buy, Sell or Hold?

  • The current Cartesian Therapeutics [RNAC] share price is $18.87. The Score for RNAC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RNAC Stock Price Chart

What is Cartesian Therapeutics's stock price today?

  • The Cartesian Therapeutics share price today is $18.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

RNAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 49.49 Sell
Chaikin Money Flow: 56766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.74 - 21.66) Sell
Bollinger Bands (100): (14.35 - 20.33) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

RNAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.5 Buy
20-day SMA: 19.15 Sell
50-day SMA: 19.39 Sell
200-day SMA: 19.98 Sell
8-day EMA: 17.91 Buy
20-day EMA: 18.75 Buy
50-day EMA: 18.93 Sell
200-day EMA: 20.95 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Cartesian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):